XML 112 R97.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Nov. 07, 2024
Nov. 06, 2024
Aug. 12, 2024
Jun. 24, 2024
Feb. 06, 2023
Jan. 10, 2023
Jan. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Sep. 30, 2024
Jun. 02, 2023
Private placement transaction $ 2,669,250             $ 4,900,000      
Common stock, par value               $ 0.001 $ 0.001    
Issuance of stock, value               $ 2,529,448      
Deduction costs of offering $ 330,750   $ 188,255                
Cancellation of restricted stock, shares               49,947 3,625    
Face value               $ 144,495 $ 147,781   $ 125,000
Conversion of convertible securities                 119,750    
Reverse stock split         1-for-20 reverse stock split            
Net loss (income) attributable to noncontrolling interests               (1,871,578) 224,598    
Nobility Healthcare LLC [Member]                      
Subsidiary ownership percentage                   49.00%  
Net loss (income) attributable to noncontrolling interests               $ 1,871,578 $ 224,598    
Nobility Healthcare LLC [Member]                      
Equity method investment ownership percentage                   51.00%  
Convertible Debt [Member]                      
Sale of common stock and pre-funded warrants, net of offering costs, shares                 25,000    
Face value                 $ 125,000    
Purchase fixed price per shares                 $ 5.00    
Conversion of convertible securities                 $ 119,750    
Pre Funded Warrants [Member]                      
Shares of common stock were exercised               573,008      
Exercise price               $ 0.0001      
Series B Warrants [Member]                      
Shares of common stock were exercised               973,000      
Shares of common stock were exercised, value               $ 973      
Fair value of warrant derivative liability               $ 584,955      
Private Placement [Member]                      
Sale of common stock and pre-funded warrants, net of offering costs, shares       1,195,219              
Share price       $ 2.51              
Pre-funded unit price       0.0001              
Common stock, par value       $ 0.001              
The Securities Purchase Agreement [Member]                      
Private placement transaction       $ 2,900,000              
Securities Purchase Agreement [Member] | Private Placement [Member]                      
Private placement transaction   $ 3,000,000.0                  
Sale of common stock and pre-funded warrants, net of offering costs, shares   808,377                  
Issuance of stock, value   $ 3,600,000                  
Officers [Member]                      
Common stock issuance granted           22,500 55,000        
Vesting drescription           Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates. Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates.        
New Employees [Member]                      
Common stock issuance granted           12,500 25,197        
New Employees [Member] | Minimum [Member]                      
Vesting period           1 year 1 year        
New Employees [Member] | Maximum [Member]                      
Vesting period           2 years 2 years